Clinical Trial Update: Comparison of Efficacy and Ocular Surface Disease Assessment Between BRIDIN-T Eye Drops 0.15% and ALPHAGAN-P Eye Drops 0.15% in Glaucoma or Ocular Hypertensive Patients : Phase 4, Parallel Group Design, Investigator-blind, Active-control, Randomized, Multi-center Trial [Phase 4]

View source ↗

Summary

Phase 4 randomized trial comparing BRIDIN-T 0.15% eye drops to ALPHAGAN-P 0.15% eye drops for efficacy and ocular surface disease in glaucoma or ocular hyperten…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• ALPHAGAN-P Eye Drops 0.15% (brimonidine tartrate)
• BRIDIN-T Eye Drops 0.15% (BRIDIN-T)

Snippet

Sponsor: CHA University | Conditions: Glaucoma, Ocular Hypertensive | Phase 4 | Status: UNKNOWN